Royalty Pharma (RPRX) Stock Price
$33.42 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
3 -
Technical
8
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Royalty Pharma, AI stock picks, stock alerts and much more.
RPRX AI Stock Analysis
AI stock analysis for RPRX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Royalty Pharma (RPRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Royalty Pharma (RPRX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Royalty Pharma (RPRX), currently trading at $33.42, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About RPRX
-
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.
-
Symbol
RPRX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
14.5B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
RPRX Alternative Data
Web Traffic
Royalty Pharma receives an estimated 11855 monthly visitors to royaltypharma.com.
-
Web Traffic
11855
-
Change from Previous Month
27.2%
-
3 Month Change
1.6%
-
YoY Change
1.6%
News Mentions
Royalty Pharma was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Royalty Pharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
LinkedIn Followers
6,962 are following Royalty Pharma on LinkedIn, up by 2.5% over the last month.
-
LinkedIn Followers
6962
-
Daily Change
0%
-
1 Month Change
2.5%
-
3 Month Change
5.2%
Job Postings
Royalty Pharma currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Royalty Pharma has 96 employees, down by -1% over the last month.
-
LinkedIn Employees
96
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
1.1%
RPRX Financials
RPRX Key Metrics
-
Total Revenue
$564.7M
-
Net Income
$544M
-
Earnings per Share
$1.22
-
Free cash flow
$1.5B
-
EBITDA
$735.1M
-
EBITDA Ratio
1.30173
-
Total Assets
$18B
RPRX 2-year Revenue & Income
RPRX 2-year Free Cash Flow
RPRX Technicals
RPRX SMA
RPRX RSI
FAQ
What's the current price of Royalty Pharma (RPRX) Stock?
The price of an Royalty Pharma (RPRX) share is $33.42.
What's the market cap of Royalty Pharma?
The current market cap of Royalty Pharma is 14.5B.
Should I buy or sell RPRX?
Royalty Pharma shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Royalty Pharma is better viewed as a hold or accumulate position while waiting for further developments.
Is Royalty Pharma a good investment?
The current analysis of Royalty Pharma's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Royalty Pharma's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Royalty Pharma (RPRX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Royalty Pharma stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Royalty Pharma (RPRX) that investors often compare it to?
Royalty Pharma (RPRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Royalty Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Royalty Pharma's stock price to be around $35.03 in 2026. Starting from the current price of $33.42, this represents a 4.8% change in price, indicating a neutral outlook for the stock.
How to buy Royalty Pharma (RPRX) Stock?
Royalty Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Royalty Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.